z-logo
Premium
Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis
Author(s) -
Silberschmidt AL,
KühnVelten WN,
Juon AM,
Zimmermann R,
Von Mandach U
Publication year - 2008
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2007.01630.x
Subject(s) - nifedipine , medicine , umbilical cord , pharmacokinetics , anesthesia , umbilical artery , gestation , pregnancy , pharmacology , calcium , anatomy , genetics , biology
Objective  To determine nifedipine concentrations in maternal plasma at steady state, and maternal and umbilical cord plasma at delivery, after tocolysis with nifedipine gastrointestinal therapeutic system (GITS) tablets. Design  Prospective clinical pharmacokinetic study. Setting  Department of Obstetrics at the Zurich University Hospital. Population  Pregnant women treated for threatened preterm labour. Methods  GITS dosage titrated to clinical response (30–150 mg/day). Nifedipine concentrations by high‐performance liquid chromatography and turbo ion spray tandem mass spectrometry. Main outcome measures  Steady‐state nifedipine concentrations in maternal blood and nifedipine concentrations in maternal and corresponding umbilical cord blood at delivery. Results  Steady‐state nifedipine concentrations (micrograms/l, mean ± SE) were 54 ± 6 (all doses, n = 31), 38 ± 8 (60 mg/day, n = 13), and 92 ± 12 (150 mg/day, n = 7) ( P < 0.002). Umbilical cord and maternal concentrations both declined in a ln‐linear regression with elimination half‐lives of 20.4 and 17.4 hours. Linear regression showed a correlation between umbilical and maternal concentrations of 0.77 ± 0.1 ( n = 21, mean ± SE). Conclusions  Steady‐state plasma nifedipine concentrations after repeated dosing with nifedipine GITS 30–150 mg/day in pregnant women with preterm labour do not exceed 100 micrograms/l; fetal levels are 77% of maternal levels.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here